LL501 (Phenobarbital 15 mg)

Pill imprint LL501 has been identified as Phenobarbital 15 mg.

Phenobarbital is used in the treatment of sedation; seizures; hyperbilirubinemia; insomnia and belongs to the drug classes barbiturate anticonvulsants, barbiturates. There is positive evidence of human fetal risk during pregnancy. Phenobarbital 15 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for LL501

Phenobarbital
Imprint:
LL501
Strength:
15 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Barbiturate anticonvulsants
Barbiturates
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Larken Laboratories, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)